点滴治療および経腸栄養用機器の欧州市場

Abstract

Expansion of Homecare Drives the Demand for European IV Therapy and Enteral Nutrition Devices

Growing demand for greater comfort, mobility and safety is driving patients to opt for flexible alternatives to institutional care. As homecare forms a better choice for many, owing to considerably lower costs and greater comfort, the expansion of this segment is likely to fuel the demand for homecare suited intravenous (IV) therapy and enteral nutrition devices. The trend towards homecare in turn is part of an overall trend in healthcare that is also reflected in the growing popularity of minimally invasive surgery, which encourages faster and less traumatic recovery for patients and promises a shorter stay in the hospital.

This Frost & Sullivan research offers a comprehensive analysis of the European IV therapy and enteral nutrition device markets. The study provides detailed insights into market trends, key drivers and restraints, industry challenges and strategic growth recommendations for market participants.

Healthcare Budgetary Constraints and Purchases by Tenders Could Dampen Growth

Increase in healthcare expenditure due to changing demographics and rapidly ageing population is resulting in huge price pressures. To combat these pressures, the government is resorting to healthcare budgetary restraints and reforms. This drive to economise is likely to affect the European IV therapy/enteral nutrition device markets negatively by further reducing prices and eroding profit margins. Offering lower prices to suit budgetary constraints is expected to be a significant challenge for the market participants.

Another factor expected to escalate price pressures and affect growth in the market is purchase by tenders. "With the rising popularity of tender purchasing, hospitals and procuring bodies are expected to gain more power in pushing down the prices of devices," notes the analyst of the research.

Product Bundling a Popular Market Strategy

In this highly fragmented market, product bundling -- of enteral feeds and devices -- is a noticeable trend. This threatens the smaller participants as larger companies offer one-stop solutions and deals on a whole set of products. Brand loyalty and consolidation further inhibit market penetration by new entrants and smaller participants. "Offering a diverse array of complimentary products and services, improved after-sales support and better delivery is likely to aid smaller companies in remaining competitive," concludes the analyst.

Table of Contents

1 EUROPEAN IV THERAPY AND ENTERAL NUTRITION DEVICE MARKETS

Introduction

• Overview

Research Scope and Methodology

• Research Scope and Methodology

Introduction and Background

• Overview
• Segmentation

Medical Device Markets: Overview

• Geographic Distribution and Regulatory Directives
• Medical Device Markets

Market Dynamics

• Industry Challenges
• Market Drivers and Restraints

IV Therapy Device Market

• Market Engineering Measurements
• Overview
• Revenue Forecast
• Geographic Distribution of Revenue
• Per cent of Revenue by Geographic Region
• Geographic Distribution of Revenue by Segments
• Competitive Analysis

Enteral Nutrition Device Market

• Market Engineering Measurements
• Revenue Forecast
• Geographic Distribution of Revenue
• Per Cent of Revenue by Geographic Region
• Competitive Analysis

Strategic Analysis and Recommendations

• Major Challenges and Strategies
• SWOT Analysis
• Customer Focus

Strategic Planning Support

• Total Surgical Procedures
• Average Length of Hospital Stay
• Bed Occupancy Rates

Competitor Profiles

• Competitor Profiles

Frost & Sullivan Awards

• Introduction to Frost & Sullivan Awards
• New Market Penetration Leadership Award
• Customer Service Leadership Award
• Competitive Strategy Leadership Award

Key Industry Participants

• Key Industry Participants

Decision Support Databases

• Malnourished Population
• Malnourished Population as Per Cent of Total Population
• Number of Hospitals
• Total Population
• Number of Hospital Beds
• Government Healthcare Expenditure
• Private Healthcare Expenditure
• Healthcare Expenditure as Per Cent of GDP
• Per Capita Healthcare Expenditure

About Frost & Sullivan

• Our Team
• Consulting Capabilities